Regulatory T Cell Function Modulated After Successful Direct-Acting Antiviral Treatment for Chronic Hepatitis C Patients
Authors:
- 1 May 2020
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 65 (5) , 1385-1395
Abstract
Backgrounds Regulatory T cells (Tregs) affect the pathogenesis of chronic hepatitis C (CHC) infection. Aims This study evaluated the function of Tregs in CHC patients receiving the standard direct-acting antiviral agents (DAA) treatment. Methods CHC patients (n = 20) who received DAA treatment, clinical data, and function of Tregs were checked at baseline, Week 4, end of treatment (EOT), and 12 weeks after EOT (SVR 12). Treg-mediated inhibition was measured. The cytokine expression and fold change of interferon (IFN)-gamma, tumor necrosis factor (TNF)-alpha, IL-10, and transforming growth factor (TGF)-beta with/without Treg inhibition were also detected. Results The cohort included 14 females with a mean age of 59.8 +/- 11.5 years. Nineteen had HCV genotype 1. The HCV RNA level was 6.17 +/- 0.70 log IU/mL. All patients reached the sustained virologic response. The frequency of CD4(+)Foxp3(+)T cells decreased from baseline to EOT and returned at SVR 12. The inhibitory function of Tregs decreased during treatment and then restored (baseline vs. EOT, P = 0.0393; EOT vs. SVR 12, P = 0.0052). The cytokine expression and fold change of IFN-gamma and TNF-alpha were highest at EOT and then decreased at SVR 12. The fold change of IL-10 was lowest at EOT and then increased at SVR 12. The fold change of TGF-beta was significantly increased at Week 4 and SVR 12 compared to baseline. Conclusions The frequency and inhibitory function of Tregs declined gradually from baseline to EOT and then increased from EOT to SVR 12 in CHC patients receiving DAA therapy. The expression of IFN-gamma, TNF-alpha, IL-10, and TGF-beta parallelled Treg function.Keywords
Funding Information
- Dalin Tzuchi General Hospital (DTCRD106(2)-E-05)
This publication has 22 references indexed in Scilit:
- Type I interferon signaling attenuates regulatory T cell function in viral infection and in the tumor microenvironmentPLOS Pathogens, 2018
- Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus–Induced Cryoglobulinemia VasculitisGastroenterology, 2017
- Increased peripheral CD4 + regulatory T cells persist after successful direct-acting antiviral treatment of chronic hepatitis CJournal of Hepatology, 2017
- Decrease in regulatory T-cell function in chronic hepatitis C patients receiving pegylated-interferon plus ribavirinInternational Journal of Infectious Diseases, 2017
- APASL consensus statements and recommendation on treatment of hepatitis CHepatology International, 2016
- Natural history of acute and chronic hepatitis CBest Practice & Research Clinical Gastroenterology, 2012
- Elevated frequency and function of regulatory T cells in patients with active chronic hepatitis CJournal of Gastroenterology, 2012
- From Vanilla to 28 Flavors: Multiple Varieties of T Regulatory CellsImmunity, 2006
- Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamideBlood, 2005
- Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-selfNature Immunology, 2005